Supervision
The oversight of firms and individuals to reduce actual and/or potential harm to consumers and markets.
Visit the Supervision dedicated microsite on this topicMiFID II – Suitability
Discover the PIMFA MIFID II – Suitability pages, featuring an in-depth analysis of ESMA’s Consultation Guidelines on the obligations of firms in MIFID business
MiFID II – Information to Clients
Discover the PIMFA MiFID II Reporting to Clients pages for comprehensive analysis on CP16/29, COBS 16 draft handbook, and ESMA Q&A on investor protection
MiFID II – Reporting to Clients
Discover the PIMFA MiFID II Reporting to Clients pages for comprehensive analysis on CP16/29, COBS 16 draft handbook, and ESMA Q&A on investor protection
MiFID II – Personal Account Dealing
Discover the PIMFA MiFID II – Personal Account Dealing pages. Download essential resources to ensure compliance and enhance your understanding of regulations
MiFID II – Inducements – Research
Discover the PIMFA MIFID II Inducements: Research page, detailing PS17/14 provisions for firms' third-party research arrangements under MiFID II regulations
MiFID II – Outsourcing
Discover the PIMFA MIFID II Outsourcing page for essential action points and insightful comments on relevant topics. Download now for comprehensive guidance
MiFID II – Compliance Function
Discover the PIMFA MIFID II Guide to the Compliance Function, featuring action points and insights on MIFID II Article 16 and Delegated Acts Article 22
MiFID II – Appropriateness
Discover the PIMFA MIFID II Guide to Appropriateness. This comprehensive guide assists firms in understanding the appropriateness assessment and related regulatory updates
FSCS and PII Costs: A Rising Tide Lifts All Boats (October 2020)
Discover insights into the significant rise in FSCS levies and Personal Indemnity Insurance premiums
FSCS Road Map: A Rising Tide Lifts All Boats (November 2020)
PIMFA advocates for urgent government and regulatory measures to enhance the FSCS Road Map, ensuring consumer confidence while addressing deeper systemic issues in the investment market.